These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4140925)

  • 1. [Systemic chemotherapy in bladder tumors].
    Revol M; Schaerer R; Faure G; Delannoy P; Bodin J
    J Urol Nephrol (Paris); 1974; 80(7-8):680-4. PubMed ID: 4140925
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bleomycin in the treatment of squamous cell carcinoma of the penis and bladder].
    Rathert P
    Urologe A; 1983 Sep; 22 Suppl():322-4. PubMed ID: 6195794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction chemotherapy with cisplatin and cyclophosphamide and maintenance chemotherapy with doxorubicin and 5-FU in advanced urinary bladder tumors.
    Sulkes A; Fuks Z
    Cancer Treat Rep; 1983 Feb; 67(2):200-1. PubMed ID: 6681734
    [No Abstract]   [Full Text] [Related]  

  • 4. Systemic chemotherapy of carcinoma of the urinary bladder.
    Maral J; Chamseddine N; Auclerc G; Jacquillat C
    Prog Clin Biol Res; 1984; 162B():107-12. PubMed ID: 6542216
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognostic significance of adjuvant cisplatin-based combination chemotherapy following radical cystectomy in patients with invasive bladder cancer.
    Muramaki M; Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
    Int J Urol; 2008 Apr; 15(4):314-8. PubMed ID: 18380818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intra-arterial chemotherapy of inoperable bladder tumors].
    Kovács J; Engloner L; Wabrosch G
    Orv Hetil; 1988 Jan; 129(3):131-3. PubMed ID: 2451199
    [No Abstract]   [Full Text] [Related]  

  • 7. [Trial of bleomycin efficacy in urinary bladder cancers].
    Nouv Presse Med; 1974 Mar; 3(10):601-2. PubMed ID: 4132637
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy of urinary bladder tumors].
    Rabkova LM
    Vopr Onkol; 1967; 13(9):52-8. PubMed ID: 4971095
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemotherapy of pleuro-pulmonary metastases].
    Chauvergne J; Lagarde C; Lacoste G; Ragni R
    Bull Cancer; 1968; 55(2):269-91. PubMed ID: 4180166
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy of metastatic bladder cancer.
    Yagoda A
    Cancer; 1980 Apr; 45(7 Suppl):1879-88. PubMed ID: 7189443
    [No Abstract]   [Full Text] [Related]  

  • 11. Systemic therapy of bladder cancer.
    Salem PA
    Prog Clin Biol Res; 1984; 162B():95-105. PubMed ID: 6209726
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of intravesical chemotherapy on superficial urinary bladder cancer].
    Moriyama M; Kubota Y; Miura T; Shuin T; Noguchi S
    Hinyokika Kiyo; 1983 Mar; 29(3):351-5. PubMed ID: 6203382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug therapy of poorly responding tumors in the metastatic stage].
    Gremmel H; Liffers R
    Med Welt; 1980 Oct; 31(43):1554-6. PubMed ID: 7464515
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of the clinical study of a preparation of diiodobenzotef in malignant tumors].
    Karev NI; Garin AM; Blokhina NG; Pershin MP; Trapeznikova MF
    Klin Med (Mosk); 1975 May; 52(5):50-3. PubMed ID: 1133992
    [No Abstract]   [Full Text] [Related]  

  • 15. [Adjuvant chemotherapy in the treatment of infiltrating cancers of the bladder. Preliminary results in 25 cases].
    Droz JP; Amiel JL; Cukier J; Beurton D; Dufour B; Pascal B
    J Urol (Paris); 1982; 88(6):369-73. PubMed ID: 7175215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy.
    Inoue K; Slaton JW; Karashima T; Yoshikawa C; Shuin T; Sweeney P; Millikan R; Dinney CP
    Clin Cancer Res; 2000 Dec; 6(12):4866-73. PubMed ID: 11156246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of cooperative clinical studies of the antineoplastic antibiotic dactinomycin].
    Titievskaia VV; Gorbunova VA; Akopiants SM; Budkevich IuV; Kuchkarev RN
    Antibiotiki; 1972 Oct; 17(10):953-8. PubMed ID: 4348682
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II trial of amsacrine (AMSA) in urinary bladder cancer.
    Natale RB; Yagoda A; Blumenreich MS; Watson RC
    Cancer Treat Rep; 1983 Apr; 67(4):391-2. PubMed ID: 6687836
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined adriamycin and 5-fluorouracil therapy in the treatment of advanced cancer of the bladder (author's transl)].
    Marcuello Gaspar E; Germá Lluch JR; Dorca Ribugent J; López Pousa A; Español Llorens J; Abad Esteve A; Avella Mestre A
    Med Clin (Barc); 1982 Jul 1-31; 79(3):107-9. PubMed ID: 7109765
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.